Publications & Reports

Association of blood lead level with neurological features in 972 children affected by an acute severe lead poisoning outbreak in Zamfara State, northern Nigeria.

Jane Greig, Natalie Thurtle, Lauren Cooney, Cono Ariti, Abdulkadir Ola Ahmed, Teshome Ashagre, Anthony Ayela, Kingsley Chukwumalu, Alison Criado-Perez, Camilo Gomez-Restrepo, Caitlin Meredith, Antonio Neri, Darryl Stellmach, Nasir Sani-Gwarzo, Abdulsalami Nasidi, Leslie Shanks, Paul I Dargan
Manson Unit, Medecins Sans Frontieres, London, United Kingdom.

Abstract

BACKGROUND: In 2010, Medecins Sans Frontieres (MSF) investigated reports of high mortality in young children in Zamfara State, Nigeria, leading to confirmation of villages with widespread acute severe lead poisoning. In a retrospective analysis, we aimed to determine venous blood lead level (VBLL) thresholds and risk factors for encephalopathy using MSF programmatic data from the first year of the outbreak response. METHODS AND FINDINGS: We included children aged </=5 years with VBLL >/=45 microg/dL before any chelation and recorded neurological status. Odds ratios (OR) for neurological features were estimated; the final model was adjusted for age and baseline VBLL, using random effects for village of residence. 972 children met inclusion criteria: 885 (91%) had no neurological features; 34 (4%) had severe features; 47 (5%) had reported recent seizures; and six (1%) had other neurological abnormalities. The geometric mean VBLLs for all groups with neurological features were >100 microg/dL vs 65.9 microg/dL for those without neurological features. The adjusted OR for neurological features increased with increasing VBLL: from 2.75, 95%CI 1.27-5.98 (80-99.9 microg/dL) to 22.95, 95%CI 10.54-49.96 (>/=120 microg/dL). Neurological features were associated with younger age (OR 4.77 [95% CI 2.50-9.11] for 1-/=80 microg/dL) and age 1-<3 years were strongly associated with neurological features; in those tested for malaria, a positive test was also strongly associated. These factors will help clinicians managing children with lead poisoning in prioritising therapy and developing chelation protocols.

Link to publisher’s web site

Publication

  • Journal: PloS One
  • Published: 16/04/2014
  • Volume: 9
  • Issue: 4
  • Pagination: e93716

Author

Program